Figure 4.
Figure 4. Cyclin D1 promoter DNA was unmethylated in normal human B and T cells. Southern blot analysis with the cyclin D1 promoter and the MTC probes and bisulfite sequencing analysis in the cyclin D1 promoter region. (A) EBV-transformed human B cells. (B) Normal human CD19+ B cells. (C) Normal human CD4+ T cells. (D) Patient samples with cyclin D1+ B-cell malignancies. For normal B and T cells, the cyclin D1 promoter was demethylated even though the gene was not expressed (Figure 1B). However, the MTC region was methylated. In 2 MCL bone marrow samples from patients (Pt 2 and Pt 3) and in a peripheral blood sample from a patient with lymphocytosis and t(11;14) B-cell malignancy (Pt 1), both the cyclin D1 promoter region (Pts 1-3) and the MTC region (Pt 1) were unmethylated in purified B cells. The methylation differences in the MTC region were confirmed by bisulfite sequencing (not shown), although the number of CpG dinucleotides in the MTC is small.

Cyclin D1 promoter DNA was unmethylated in normal human B and T cells. Southern blot analysis with the cyclin D1 promoter and the MTC probes and bisulfite sequencing analysis in the cyclin D1 promoter region. (A) EBV-transformed human B cells. (B) Normal human CD19+ B cells. (C) Normal human CD4+ T cells. (D) Patient samples with cyclin D1+ B-cell malignancies. For normal B and T cells, the cyclin D1 promoter was demethylated even though the gene was not expressed (Figure 1B). However, the MTC region was methylated. In 2 MCL bone marrow samples from patients (Pt 2 and Pt 3) and in a peripheral blood sample from a patient with lymphocytosis and t(11;14) B-cell malignancy (Pt 1), both the cyclin D1 promoter region (Pts 1-3) and the MTC region (Pt 1) were unmethylated in purified B cells. The methylation differences in the MTC region were confirmed by bisulfite sequencing (not shown), although the number of CpG dinucleotides in the MTC is small.

Close Modal

or Create an Account

Close Modal
Close Modal